Prof. Dr. Niranjan Hiremath
“Cardiovascular education has to be precise. Patients need clear explanations of risk, treatment options, and when specialist care is necessary.”
A Cardiovascular and Aortic Surgeon Reviewing Patient-Facing Heart Content
Prof. Dr. Niranjan Hiremath is an internationally trained cardiovascular and aortic surgeon based in Bengaluru, India. He is associated with Apollo Hospitals, where his clinical work focuses on complex cardiac, aortic, vascular, endovascular, and structural heart procedures.
Apollo Hospitals lists Dr. Hiremath as a Senior Consultant in Cardiovascular and Aortic Surgery with more than 14 years of experience. His listed qualifications include MS, FVES in Vascular Surgery, MCh in Cardiothoracic Surgery, FACS (Aus.), FCAS in Aortic Surgery and TAVI from Canada, and FIACS.
His public Apollo profile states that he leads the Pan Apollo Aortic Surgical Program and serves as Surgical Lead of the Aortic Center of Excellence. Apollo also lists prior roles as Assistant Professor of Cardiac Surgery at Cleveland Clinic, Ohio, and Specialist Cardiac Surgeon at Cleveland Clinic Abu Dhabi.
His SunnyPharma® role focuses on cardiovascular content review, including clinical accuracy, safety framing, and clear explanation for patient-facing medical education.
Heart and vascular information should not create false reassurance or unnecessary fear. The reviewer’s job is to keep the clinical message accurate, cautious, and understandable.
Apollo-Listed Publications and Academic Work
The following works are listed on Dr. Hiremath’s Apollo247 profile. SunnyPharma® treats these as Apollo-listed publications unless independently indexed publication pages are available.
-
The “On-Pump Modified Branch-First Technique” for challenging Type I and Type IV thoracoabdominal aortic aneurysmsUnder revision
Cardiovascular, Aortic, and Structural Heart Review Coverage
Dr. Hiremath’s review scope for SunnyPharma® is aligned to his publicly listed surgical and cardiovascular expertise. This includes patient-facing education on cardiovascular disease, coronary artery disease, aortic aneurysm and dissection, valve disease, TAVI, CABG, EVAR, TEVAR, and procedural-risk framing.
-
Aortic aneurysm and aortic dissection education
-
Structural heart and valve-disease education
-
Coronary artery disease and CABG education
-
Anticoagulant and cardiovascular medication context
How Dr. Hiremath Reviews SunnyPharma® Cardiovascular Content
Every cardiovascular article assigned for medical review is checked for clinical accuracy, appropriate caution, and patient comprehension. Content involving anticoagulants, heart procedures, aortic disease, or valve disease is reviewed to avoid overstating benefits, minimizing bleeding or procedural risks, or implying that online information can replace an individual clinician’s judgment.
Review role. Dr. Hiremath reviews SunnyPharma® cardiovascular education content for clinical accuracy, appropriate medical context, and patient readability.
Scope of review. His review focuses on cardiovascular disease, aortic disease, structural heart procedures, coronary disease, anticoagulant safety framing, and related patient-education topics.
Disclosure. Publicly available Indian physician profiles do not provide a centralized payment-disclosure database equivalent to the U.S. CMS Open Payments system. Any relevant professional relationships should be disclosed before final publication.